Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,504 | -14,238 | -9,299 | -3,956 | -17,984 |
| Depreciation Amortization | 446 | 345 | 246 | 35 | -1,388 |
| Other Working Capital | 140 | 152 | 619 | -708 | 2,342 |
| Other Operating Activity | 433 | 416 | 232 | 126 | 2,364 |
| Operating Cash Flow | $-16,485 | $-13,325 | $-8,202 | $-4,503 | $-14,666 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -8 | -8 | -8 | -118 |
| Investing Cash Flow | $-8 | $-8 | $-8 | $-8 | $-118 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 4,000 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -7 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $3,993 |
| Beginning Cash Position | 26,428 | 26,428 | 26,428 | 26,428 | 37,219 |
| End Cash Position | 9,935 | 13,095 | 18,218 | 21,917 | 26,428 |
| Net Cash Flow | $-16,493 | $-13,333 | $-8,210 | $-4,511 | $-10,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,485 | -13,325 | -8,202 | -4,503 | -14,666 |
| Capital Expenditure | -8 | -8 | -8 | -8 | -118 |
| Free Cash Flow | -16,493 | -13,333 | -8,210 | -4,511 | -14,784 |